Butterfly NetworkFRA:7JA +1.63%40 PB Ratio is 11.34 as of Jul. 11, 2026, which is 409% above its 10-year median of 2.23. GuruFocus rates FRA:7JA with a GF Score™ of 40/100 and a GF Value™ of €2.06 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Butterfly Network ranks worse than 92.37% on this metric.
Butterfly Network Inc stock PB Ratio (=10.96) is close to 10-year high of 12.16.
The historical rank and industry rank for Butterfly Network's PB Ratio or its related term are showing as below:
FRA:7JA'
s PB Ratio Range Over the Past 10 Years
Min: 0.63 Med: 2.23 Max: 12.16
Current: 11.14
During the past 7 years, Butterfly Network's highest PB Ratio was 12.16. The lowest was 0.63. And the median was 2.23.
FRA:7JA's PB Ratio is ranked worse than 92.37% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs FRA:7JA: 11.14
During the past 12 months, Butterfly Network's average Book Value Per Share Growth Rate was -24.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -21.90% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Butterfly Network was -21.90% per year. The lowest was -29.70% per year. And the median was -25.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Butterfly Network PB Ratio Related Terms
Butterfly Network PB Ratio Historical Data
* Premium members only.
The historical data trend for Butterfly Network's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Butterfly Network's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Butterfly Network PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Butterfly Network's PB Ratio distribution charts can be found below:
* The bar in red indicates where Butterfly Network's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Butterfly Network (FRA:7JA) has a PB Ratio of 11.34 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Butterfly Network and its competitors. This is 409% above median its historical median of 2.23. Over the past decade, Butterfly Network's PB Ratio has ranged from 0.63 to 12.16. According to the industry distribution chart, Butterfly Network ranks #726 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 92.4%.
Is Butterfly Network's PB Ratio too high?
Butterfly Network's current PB Ratio of 11.34 is 409% above median its 10-year median of 2.23. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 12.16. The Medical Devices & Instruments industry median PB Ratio is 2.06. Butterfly Network's value of 11.34 is 450.5% above this industry median. Based on the distribution chart, Butterfly Network ranks #726 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Butterfly Network has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Butterfly Network's PB Ratio compare to TMDX and AXGN?
According to the Medical Devices & Instruments industry distribution chart, Butterfly Network ranks #726 out of 786 companies for PB Ratio. This places Butterfly Network in the lower half of its industry. The industry median PB Ratio is 2.06. Butterfly Network's value of 11.34 is 450.5% above this benchmark. Historically, Butterfly Network's own PB Ratio has ranged from 0.63 to 12.16 over the past decade. While the company's 10-year median is 2.23 vs. the industry median of 2.06, Butterfly Network has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.06, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Butterfly Network's current PB Ratio of 11.34 is 450.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Butterfly Network and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Butterfly Network's current PB Ratio is 11.34, which is 409% above median its own 10-year median of 2.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Butterfly Network stock overvalued right now?
Based on GuruFocus' analysis, Butterfly Network (FRA:7JA) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.06, compared to a current price of €7.18 — trading 248.5% above its estimated fair value. The current PB Ratio is 11.34, which is 409% above median its 10-year median of 2.23 and 450.5% above the Medical Devices & Instruments industry median of 2.06. Butterfly Network's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Butterfly Network (FRA:7JA), the current PB Ratio is 11.34 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Butterfly Network (FRA:7JA) Overvalued in 2026?
Based on GuruFocus' analysis, Butterfly Network stock appears to be overvalued.
The current stock price of €7.18 is trading 248.5% above its estimated GF Value™ of €2.06.
GuruFocus considers Butterfly Network to be Significantly Overvalued.
Key valuation signals for FRA:7JA:
PB Ratio: 11.34 (409% above median its 10-year median of 2.23)
GF Value™: €2.06 vs. price of €7.18 (248.5% above fair value)
Industry Position: 450.5% above the Medical Devices & Instruments median (#726 of 786)
No single metric tells the full story. See the FRA:7JA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
40GF Score
Get the complete analysis for FRA:7JA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7JA has been successfully added to your 
